And NO WAY does SOON "shelve" the NDA/Aldox, leaving NOTHING for CYTR, as some have stated elsewhere. SOON didn't buy Aldox, he licensed it with the responsibility of commercialization. Only if Aldox is denied FDA approval would it be "shelved", which I feel is highly unlikely given trial results with an already approved SOC drug. SOON may delay either for justifiable reasons but that's about it. I'm sure SK remains in the loop and is fully aware of where everything stands at any given time. SOON we will know as well, or at least more than we do now. ;p
All IMO. GN, GLTA and CYTR!